|
Platelet function inhibitors
Citations 1-10 of 220 total displayed.
|
Most recent content
(13 Oct 2008):
|
- Articles
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. A Systematic Review
- Pieter J. Vlaar, Tone Svilaas, Kevin Damman, Bart J.G.L. de Smet, Jan G.P. Tijssen, Hans L. Hillege, and Felix Zijlstra
Circulation published October 13, 2008, doi:10.1161/CIRCULATIONAHA.107.749531
[Abstract]
|
Past content
(since Oct 2000):
|
- Articles
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid. Determinants and Effect on Cardiovascular Risk
- John W. Eikelboom, Graeme J. Hankey, Jim Thom, Deepak L. Bhatt, P. Gabriel Steg, Gilles Montalescot, S. Claiborne Johnston, Steven R. Steinhubl, Koon-Hou Mak, J. Donald Easton, Christian Hamm, Tingfei Hu, Keith A.A. Fox, Eric J. Topol on behalf of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators
Circulation published October 6, 2008, doi:10.1161/CIRCULATIONAHA.108.768283
[Abstract]
- Articles
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- Stephen D. Wiviott, Eugene Braunwald, Dominick J. Angiolillo, Simha Meisel, Anthony J. Dalby, Freek W.A. Verheugt, Shaun G. Goodman, Ramon Corbalan, Drew A. Purdy, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman for the TRITON-TIMI 38 Investigators
Circulation published August 31, 2008, doi:10.1161/CIRCULATIONAHA.108.791061
[Abstract]
- Editorials
Intracoronary Administration of Abciximab in ST-Elevation Myocardial Infarction
- C. Michael Gibson, Cafer Zorkun, and Vijayalakshmi Kunadian
Circulation 2008; 118: 6-8, doi:10.1161/CIRCULATIONAHA.108.780718
[Full text]
- Interventional Cardiology
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
- Holger Thiele, Kathrin Schindler, Josef Friedenberger, Ingo Eitel, Georg Fürnau, Eigk Grebe, Sandra Erbs, Axel Linke, Sven Möbius-Winkler, Dietmar Kivelitz, and Gerhard Schuler
Circulation 118: 49 -57; published online before print as doi:10.1161/CIRCULATIONAHA.107.747642
[Abstract]
[Full text]
- Articles
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
- Holger Thiele, Kathrin Schindler, Josef Friedenberger, Ingo Eitel, Georg Fürnau, Eigk Grebe, Sandra Erbs, Axel Linke, Sven Möbius-Winkler, Dietmar Kivelitz, and Gerhard Schuler
Circulation published June 16, 2008, doi:10.1161/CIRCULATIONAHA.107.747642
[Abstract]
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 117: 2865 -2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
- Articles
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
- Editorials
Damage Control for Renal Artery Stenting
- John A. Bittl
Circulation 2008; 117: 2724-2726, doi:10.1161/CIRCULATIONAHA.108.776732
[Full text]
- Pediatric Cardiology
Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial
- Jennifer S. Li, Eric Yow, Katherine Y. Berezny, Paula M. Bokesch, Matsato Takahashi, Thomas P. Graham, Jr, Stephen P. Sanders, Daniel Sidi, Damien Bonnet, Peter Ewert, Lisa K. Jennings, Alan D. Michelson for the PICOLO Investigators
Circulation 117: 553 -559; published online before print as doi:10.1161/CIRCULATIONAHA.107.715821
[Abstract]
[Full text]
|
|
